ResultsIQ

ResultsIQ › Latest results › Shree Ganesh Remedies Limited

Shree Ganesh Remedies Limited Q2 FY27 results deck summary

NSE: SGRL · BSE: 540737

Results deck of 1 Nov 2026, summarised by AI from the filing.

Q2 FY27 revenue was ₹23.29 cr (-23% YoY) and PAT ₹1.63 cr (-67%), with management expecting the core business to recover over the next few quarters.

Key takeaways

  1. Margin fall EBITDA margin fell to 16.9% in Q2 FY27 from 23.3% in Q1 FY27, a fall of 644 bps.
  2. New products Commercial production of two new pharmaceutical intermediates began, and the first South-East Asia specialty product is expected to supply commercially from Q1 FY28.

Original filing on BSE

Shree Ganesh Remedies Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.